Metabolites
Displaying compounds 11926 - 11950 of 16042 in total
| YMDB ID | Name CAS Number | IUPAC Name | Formula Weight | Structure |
|---|---|---|---|---|
| YMDB12222 | CDP-DG(15:0/20:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-2-(icosanoyloxy)-3-(pentadecanoyloxy)propoxy]phosphoryl}oxy)phosphinic acid | C47H87N3O15P2 996.167 | |
| YMDB12223 | CDP-DG(15:0/20:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-2-[(11Z)-icos-11-enoyloxy]-3-(pentadecanoyloxy)propoxy]phosphoryl}oxy)phosphinic acid | C47H85N3O15P2 994.151 | |
| YMDB12224 | CDP-DG(15:0/20:1(13Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-2-[(13Z)-icos-13-enoyloxy]-3-(pentadecanoyloxy)propoxy]phosphoryl}oxy)phosphinic acid | C47H85N3O15P2 994.151 | |
| YMDB12225 | CDP-DG(15:0/22:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-(docosanoyloxy)-3-(pentadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C49H91N3O15P2 1024.221 | |
| YMDB12226 | CDP-DG(15:0/22:1(13Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(13Z)-docos-13-enoyloxy]-3-(pentadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C49H89N3O15P2 1022.205 | |
| YMDB12227 | CDP-DG(15:0/22:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(9Z)-docos-9-enoyloxy]-3-(pentadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C49H89N3O15P2 1022.205 | |
| YMDB12228 | CDP-DG(15:0/23:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-3-(pentadecanoyloxy)-2-[(11Z)-tricos-11-enoyloxy]propoxy]phosphoryl}oxy)phosphinic acid | C50H91N3O15P2 1036.232 | |
| YMDB12229 | CDP-DG(15:0/23:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-3-(pentadecanoyloxy)-2-[(9Z)-tricos-9-enoyloxy]propoxy]phosphoryl}oxy)phosphinic acid | C50H91N3O15P2 1036.232 | |
| YMDB12230 | CDP-DG(15:0/24:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-3-(pentadecanoyloxy)-2-(tetracosanoyloxy)propoxy]phosphoryl}oxy)phosphinic acid | C51H95N3O15P2 1052.275 | |
| YMDB12231 | CDP-DG(15:0/24:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-3-(pentadecanoyloxy)-2-[(11Z)-tetracos-11-enoyloxy]propoxy]phosphoryl}oxy)phosphinic acid | C51H93N3O15P2 1050.259 | |
| YMDB12232 | CDP-DG(15:0/24:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-3-(pentadecanoyloxy)-2-[(9Z)-tetracos-9-enoyloxy]propoxy]phosphoryl}oxy)phosphinic acid | C51H93N3O15P2 1050.259 | |
| YMDB12233 | CDP-DG(15:0/25:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-2-(pentacosanoyloxy)-3-(pentadecanoyloxy)propoxy]phosphoryl}oxy)phosphinic acid | C52H97N3O15P2 1066.302 | |
| YMDB12234 | CDP-DG(15:0/25:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-2-[(11Z)-pentacos-11-enoyloxy]-3-(pentadecanoyloxy)propoxy]phosphoryl}oxy)phosphinic acid | C52H95N3O15P2 1064.286 | |
| YMDB12235 | CDP-DG(15:0/25:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-2-[(9Z)-pentacos-9-enoyloxy]-3-(pentadecanoyloxy)propoxy]phosphoryl}oxy)phosphinic acid | C52H95N3O15P2 1064.286 | |
| YMDB12236 | CDP-DG(15:0/26:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-(hexacosanoyloxy)-3-(pentadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C53H99N3O15P2 1080.329 | |
| YMDB12237 | CDP-DG(15:0/26:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(12Z)-hexacos-12-enoyloxy]-3-(pentadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C53H97N3O15P2 1078.313 | |
| YMDB12238 | CDP-DG(15:0/26:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(10Z)-heptacos-10-enoyloxy]-3-(pentadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C54H99N3O15P2 1092.34 | |
| YMDB12239 | CDP-DG(15:0/27:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-(heptacosanoyloxy)-3-(pentadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C54H101N3O15P2 1094.356 | |
| YMDB12240 | CDP-DG(15:0/27:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(11Z)-heptacos-11-enoyloxy]-3-(pentadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C54H99N3O15P2 1092.34 | |
| YMDB12241 | CDP-DG(15:0/27:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(9Z)-heptacos-9-enoyloxy]-3-(pentadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C54H99N3O15P2 1092.34 | |
| YMDB12242 | CDP-DG(15:0/28:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-2-(octacosanoyloxy)-3-(pentadecanoyloxy)propoxy]phosphoryl}oxy)phosphinic acid | C55H103N3O15P2 1108.383 | |
| YMDB12243 | CDP-DG(15:0/28:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-2-[(12Z)-octacos-12-enoyloxy]-3-(pentadecanoyloxy)propoxy]phosphoryl}oxy)phosphinic acid | C55H101N3O15P2 1106.367 | |
| YMDB12244 | CDP-DG(15:0/28:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-2-[(10Z)-octacos-10-enoyloxy]-3-(pentadecanoyloxy)propoxy]phosphoryl}oxy)phosphinic acid | C55H101N3O15P2 1106.367 | |
| YMDB12245 | CDP-DG(15:0/29:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-2-(nonacosanoyloxy)-3-(pentadecanoyloxy)propoxy]phosphoryl}oxy)phosphinic acid | C56H105N3O15P2 1122.41 | |
| YMDB12246 | CDP-DG(15:0/30:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-3-(pentadecanoyloxy)-2-(triacontanoyloxy)propoxy]phosphoryl}oxy)phosphinic acid | C57H107N3O15P2 1136.437 |